|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Hospital Organization Kinki-chuo Chest Medical Center |
|---|---|
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00242983 |
Purpose
RATIONALE: Studying quality-of-life in patients undergoing cancer treatment may help identify the intermediate and long-term effects of treatment on patients with cancer.
PURPOSE: This clinical trial is studying quality of life in patients who are receiving either vinorelbine, gemcitabine, and docetaxel or paclitaxel and carboplatin for advanced non-small cell lung cancer.
| Condition | Intervention |
|---|---|
|
Lung Cancer |
Procedure: quality-of-life assessment |
| Study Type: | Observational |
| Official Title: | Assessment of Quality of Life (QOL) in Patients Registered With "Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)" |
| Study Start Date: | April 2004 |
OBJECTIVES:
OUTLINE: This is a multicenter study. Patients receive treatment on protocol JMTO-LC00-03.
Quality of life is assessed using the Functional Assessment of Cancer Therapy-Lung (FACT-L), FACT-Taxane, and Functional Assessment of Chronic Illness Therapy-Spirituality (FACIT-Sp) questionnaires at baseline, weeks 9 and 18, and at the completion of treatment.
PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed primary non-small cell lung cancer, including any of the following:
Any of the following cellular subtypes are allowed:
PATIENT CHARACTERISTICS:
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
PRIOR CONCURRENT THERAPY:
Radiotherapy
Surgery
Contacts and Locations| Japan | |
| Asahikawa Medical College | |
| Asahikawa, Japan, 078 8510 | |
| Fujisawa City Hospital | |
| Kanagawa, Japan, 251-8550 | |
| Gunma Cancer Center | |
| Gunma, Japan, 373-8550 | |
| Ichinomiyanishi Hospital | |
| Aichi, Japan, 491-0201 | |
| Junshinkai Tsuna Hospital | |
| Hyogo, Japan, 663-8501 | |
| Koseiren Takaoka Hospital | |
| Toyama, Japan, 933-8555 | |
| Miyagi Cancer Center | |
| Miyagi, Japan, 981-1293 | |
| National Cancer Center Hospital East | |
| Chiba-ken, Japan, 277-8577 | |
| National Hospital Organization - Dohoku National Hospital | |
| Hokkaido, Japan, 070-0901 | |
| National Hospital Organization - Minamikyoto Medical Center | |
| Kyoto, Japan, 610-0113 | |
| Toyohashi Municipal Hospital | |
| Aichi, Japan, 466-8560 | |
| National Hospital Organization - Okayama Medical Center | |
| Okayama, Japan, 701-1192 | |
| National Hospital Organization - Osaka National Hospital | |
| Osaka, Japan, 591-8555 | |
| Osaka General Medical Center | |
| Osaka-shi, Japan, 558-0056 | |
| Osaka Kosei Nenkin Hospital | |
| Osaka, Japan, 553-0003 | |
| Saitama Cardiovascular and Respiratory Center | |
| Saitama, Japan, 360-0105 | |
| Shikoku Cancer Center Hospital | |
| Ehime, Japan, 790-0007 | |
| Takarazuka Municipal Hospital | |
| Hyogo, Japan, 665-0827 | |
| Tokyo Medical University | |
| Tokyo, Japan, 160 | |
| Tottori University Hospital | |
| Tottori, Japan, 683-8504 | |
| National Hospital Organization - Nishigunma National Hospital | |
| Gumna, Japan, 377-8511 | |
| Study Chair: | Masaaki Kawahara, MD | National Hospital Organization - Osaka National Hospital |
More Information
| Study ID Numbers: | CDR0000450163, NHOK-BRI-LC03-01 |
| Study First Received: | October 20, 2005 |
| Last Updated: | July 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00242983 |
| Health Authority: | United States: Federal Government |
|
adenocarcinoma of the lung large cell lung cancer recurrent non-small cell lung cancer |
squamous cell lung cancer stage IIIB non-small cell lung cancer stage IV non-small cell lung cancer |
|
Thoracic Neoplasms Non-small cell lung cancer Quality of Life Carboplatin Recurrence Carcinoma Docetaxel Vinorelbine Adenocarcinoma of lung |
Respiratory Tract Diseases Paclitaxel Lung Neoplasms Lung Diseases Adenocarcinoma Gemcitabine Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |
|
Respiratory Tract Neoplasms Neoplasms Neoplasms by Site Neoplasms by Histologic Type |
Antineoplastic Agents Therapeutic Uses Antineoplastic Agents, Phytogenic Pharmacologic Actions |
